Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain

Pneumococcal pneumonia is a serious cause of morbidity and mortality in the elderly, but investigation of the etiological agent of community-acquired pneumonia (CAP) is not possible in most hospitalized patients. The aim of this study was to estimate the effect of pneumococcal polysaccharide vaccina...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2017-02, Vol.12 (2), p.e0171943
Hauptverfasser:	Domínguez, Àngela, Soldevila, Núria, Toledo, Diana, Torner, Núria, Force, Luis, Pérez, María José, Martín, Vicente, Rodríguez-Rojas, Lourdes, Astray, Jenaro, Egurrola, Mikel, Sanz, Francisco, Castilla, Jesús
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aged, 80 and over Analysis Biology and Life Sciences Care and treatment Case-Control Studies Communities Community-Acquired Infections - epidemiology Community-Acquired Infections - prevention & control Community-Acquired Infections - therapy Diagnosis Disease prevention Etiology Female Geriatrics Hospitalization Hospitalization - statistics & numerical data Humans Immunization Immunocompromised hosts Male Medicine and Health Sciences Morbidity Mortality Multivariate analysis Older people Patients People and Places Persones grans Pneumococcal pneumonia Pneumococcal Vaccines - therapeutic use Pneumonia Pneumonia, Pneumococcal - epidemiology Pneumonia, Pneumococcal - prevention & control Pneumonia, Pneumococcal - therapy Pneumònia Polisacàrids Polysaccharides Prevention Regression analysis Risk reduction Spain Streptococcus infections Streptococcus pneumoniae Treatment outcome Vaccination Vaccination - statistics & numerical data Vaccine efficacy Vaccines Vacunes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!